Article Information
History
- November 13, 2024.
Article Versions
- Version 1 (August 28, 2024 - 18:43).
- Version 2 (August 30, 2024 - 09:31).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pauline Lanting1,2,3,$,*,
- Robert Warmerdam1,3,*,
- Jelle Slager1,
- Harm Brugge1,
- Taichi Ochi4,
- Marloes Benjamins1,
- Esteban Lopera-Maya1,
- Soesma Jankipersadsing1,
- Jody Gelderloos-Arends1,
- Daphne Teuben1,
- Dennis Hendriksen1,6,
- Bart Charbon1,6,
- Lennart Johansson1,6,
- Thijs Oude Munnink2,
- Nienke de Boer-Veger5,
- Lifelines NEXT,
- LifeLines Cohort Study,
- Bob Wilffert2,4,†,
- Morris Swertz1,6,
- Daan Touw2,
- Patrick Deelen1,3,
- Nine Knoers1,
- Jackie Dekens1,7,# and
- Lude Franke1,3,#
- 1Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- 2Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- 3Oncode Institute, Utrecht, The Netherlands
- 4Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands
- 5Service Apotheek Boterdiep, Groningen, The Netherlands
- 6Genomics Coordination Center, Groningen, The Netherlands
- 7Center for Development and Innovation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- ↵$Corresponding author; email: p.lanting{at}umcg.nl
↵* Contributed equally
Posted November 13, 2024.
Low-cost generation of clinical-grade layperson-friendly pharmacogenetic passports using oligonucleotide arrays
